Real-world Aliskiren Use in Diabetic Patients

Completed

Conditions studied: Diabetes, Hypertension

In brief

The purpose of this study is to evaluate real-world patterns of aliskiren use with a focus of change in renal function following aliskiren initiation as well as to identify "triggering events" that lead to aliskiren initiation.

Key facts

Study ID

NCT01393860

Run by

Novartis

People needed

200

Starts

2010-12-01

Last updated by the study team

2011-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes
• Patients ages 18 yeras and older
• Hypertension Diagnosis
• Currently on at least 1 hypertensive medication
• At least 2 lab measure before and after aliskiren initiation

You may not qualify if…

• Inadequate chart records where microalbuminuria, serum creatinine and blood pressure data are not within 3-12 months prior to initiation of Aliskiren
• Pregnancy
• Development of secondary renal disease unrelated to diabetes (such as nephritis)
• Terminal illness
• AIDS/HIV Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• MODEL Clinical Research, Research Division of Bay Endocrinology Associates GBMC Physicians pavilion North — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.